Report for Davis A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (17)

Title : Organophosphate toxicity patterns: A new approach for assessing organophosphate neurotoxicity - Karaboga_2024_J.Hazard.Mater_470_134236
Author(s) : Karaboga S , Severac F , Collins ES , Stab A , Davis A , Souchet M , Herve G
Ref : J Hazard Mater , 470 :134236 , 2024
Abstract : Karaboga_2024_J.Hazard.Mater_470_134236
ESTHER : Karaboga_2024_J.Hazard.Mater_470_134236
PubMedSearch : Karaboga_2024_J.Hazard.Mater_470_134236
PubMedID: 38613959

Title : Solvents and detergents compatible with enzyme kinetic studies of cholinesterases - Sands_2023_Chem.Biol.Interact_14ChEPon_110667
Author(s) : Sands D , Davis A , Banfield S , Pottie IR , Darvesh S
Ref : Chemico-Biological Interactions , :110667 , 2023
Abstract : Sands_2023_Chem.Biol.Interact_14ChEPon_110667
ESTHER : Sands_2023_Chem.Biol.Interact_14ChEPon_110667
PubMedSearch : Sands_2023_Chem.Biol.Interact_14ChEPon_110667
PubMedID: 37579937

Title : Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation - Malek_2022_Molecules_28_
Author(s) : Malek R , Simakov A , Davis A , Maj M , Bernard PJ , Wnorowski A , Martin H , Marco-Contelles J , Chabchoub F , Dallemagne P , Rochais C , Jozwiak K , Ismaili L
Ref : Molecules , 28 : , 2022
Abstract : Malek_2022_Molecules_28_
ESTHER : Malek_2022_Molecules_28_
PubMedSearch : Malek_2022_Molecules_28_
PubMedID: 36615267

Title : Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer's Disease Treatment through Rigidification Strategy - Lecoutey_2021_Molecules_26_
Author(s) : Lecoutey C , Legay R , Davis A , Sopkova-de Oliveira Santos J , Dallemagne P , Rochais C
Ref : Molecules , 26 : , 2021
Abstract : Lecoutey_2021_Molecules_26_
ESTHER : Lecoutey_2021_Molecules_26_
PubMedSearch : Lecoutey_2021_Molecules_26_
PubMedID: 33926141

Title : Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease Treatment - Seguy_2021_Pharmaceutics_13_
Author(s) : Seguy L , Guyon L , Maurel M , Verdie P , Davis A , Corvaisier S , Lisowski V , Dallemagne P , Groo AC , Malzert-Freon A
Ref : Pharmaceutics , 13 : , 2021
Abstract : Seguy_2021_Pharmaceutics_13_
ESTHER : Seguy_2021_Pharmaceutics_13_
PubMedSearch : Seguy_2021_Pharmaceutics_13_
PubMedID: 34683919

Title : Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease - Chretien_2021_Br.J.Clin.Pharmacol_87_2830
Author(s) : Chretien B , Jourdan JP , Davis A , Fedrizzi S , Bureau R , Sassier M , Rochais C , Alexandre J , Lelong-Boulouard V , Dolladille C , Dallemagne P
Ref : British Journal of Clinical Pharmacology , 87 :2830 , 2021
Abstract : Chretien_2021_Br.J.Clin.Pharmacol_87_2830
ESTHER : Chretien_2021_Br.J.Clin.Pharmacol_87_2830
PubMedSearch : Chretien_2021_Br.J.Clin.Pharmacol_87_2830
PubMedID: 33274491

Title : Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment - Adnet_2020_Pharmaceutics_12_
Author(s) : Adnet T , Groo AC , Picard C , Davis A , Corvaisier S , Since M , Bounoure F , Rochais C , Pluart LL , Dallemagne P , Malzert-Freon A
Ref : Pharmaceutics , 12 : , 2020
Abstract : Adnet_2020_Pharmaceutics_12_
ESTHER : Adnet_2020_Pharmaceutics_12_
PubMedSearch : Adnet_2020_Pharmaceutics_12_
PubMedID: 32168767

Title : First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer's Disease - Guieu_2020_Molecules_26_
Author(s) : Guieu B , Lecoutey C , Legay R , Davis A , Sopkova de Oliveira Santos J , Altomare CD , Catto M , Rochais C , Dallemagne P
Ref : Molecules , 26 : , 2020
Abstract : Guieu_2020_Molecules_26_
ESTHER : Guieu_2020_Molecules_26_
PubMedSearch : Guieu_2020_Molecules_26_
PubMedID: 33375412

Title : Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT(6) receptor antagonist with therapeutic interest in Alzheimer's disease - Toublet_2020_Eur.J.Med.Chem_210_113059
Author(s) : Toublet FX , Lalut J , Hatat B , Lecoutey C , Davis A , Since M , Corvaisier S , Freret T , Sopkova-de Oliveira Santos J , Claeysen S , Boulouard M , Dallemagne P , Rochais C
Ref : Eur Journal of Medicinal Chemistry , 210 :113059 , 2020
Abstract : Toublet_2020_Eur.J.Med.Chem_210_113059
ESTHER : Toublet_2020_Eur.J.Med.Chem_210_113059
PubMedSearch : Toublet_2020_Eur.J.Med.Chem_210_113059
PubMedID: 33310288

Title : Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease - Lalut_2020_Sci.Rep_10_3014
Author(s) : Lalut J , Payan H , Davis A , Lecoutey C , Legay R , Sopkova-de Oliveira Santos J , Claeysen S , Dallemagne P , Rochais C
Ref : Sci Rep , 10 :3014 , 2020
Abstract : Lalut_2020_Sci.Rep_10_3014
ESTHER : Lalut_2020_Sci.Rep_10_3014
PubMedSearch : Lalut_2020_Sci.Rep_10_3014
PubMedID: 32080261

Title : A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer's Disease - Hatat_2019_Front.Aging.Neurosci_11_148
Author(s) : Hatat B , Yahiaoui S , Lecoutey C , Davis A , Freret T , Boulouard M , Claeysen S , Rochais C , Dallemagne P
Ref : Front Aging Neurosci , 11 :148 , 2019
Abstract : Hatat_2019_Front.Aging.Neurosci_11_148
ESTHER : Hatat_2019_Front.Aging.Neurosci_11_148
PubMedSearch : Hatat_2019_Front.Aging.Neurosci_11_148
PubMedID: 31316368

Title : Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's Disease - Toublet_2019_Molecules_24_
Author(s) : Toublet FX , Lecoutey C , Lalut J , Hatat B , Davis A , Since M , Corvaisier S , Freret T , Sopkova de Oliveira Santos J , Claeysen S , Boulouard M , Dallemagne P , Rochais C
Ref : Molecules , 24 : , 2019
Abstract : Toublet_2019_Molecules_24_
ESTHER : Toublet_2019_Molecules_24_
PubMedSearch : Toublet_2019_Molecules_24_
PubMedID: 31370232

Title : Novel multitarget-directed ligands targeting acetylcholinesterase and sigma1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase - Lalut_2019_Eur.J.Med.Chem_162_234
Author(s) : Lalut J , Santoni G , Karila D , Lecoutey C , Davis A , Nachon F , Silman I , Sussman JL , Weik M , Maurice T , Dallemagne P , Rochais C
Ref : Eur Journal of Medicinal Chemistry , 162 :234 , 2019
Abstract : Lalut_2019_Eur.J.Med.Chem_162_234
ESTHER : Lalut_2019_Eur.J.Med.Chem_162_234
PubMedSearch : Lalut_2019_Eur.J.Med.Chem_162_234
PubMedID: 30447434
Gene_locus related to this paper: torca-ACHE

Title : Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease - Yahiaoui_2016_Eur.J.Med.Chem_121_283
Author(s) : Yahiaoui S , Hamidouche K , Ballandonne C , Davis A , de Oliveira Santos JS , Freret T , Boulouard M , Rochais C , Dallemagne P
Ref : Eur Journal of Medicinal Chemistry , 121 :283 , 2016
Abstract : Yahiaoui_2016_Eur.J.Med.Chem_121_283
ESTHER : Yahiaoui_2016_Eur.J.Med.Chem_121_283
PubMedSearch : Yahiaoui_2016_Eur.J.Med.Chem_121_283
PubMedID: 27266998

Title : Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography - Lalut_2016_Eur.J.Med.Chem_116_90
Author(s) : Lalut J , Tournier BB , Cailly T , Lecoutey C , Corvaisier S , Davis A , Ballandonne C , Since M , Millet P , Fabis F , Dallemagne P , Rochais C
Ref : Eur Journal of Medicinal Chemistry , 116 :90 , 2016
Abstract : Lalut_2016_Eur.J.Med.Chem_116_90
ESTHER : Lalut_2016_Eur.J.Med.Chem_116_90
PubMedSearch : Lalut_2016_Eur.J.Med.Chem_116_90
PubMedID: 27060761

Title : Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7) - Gault_1998_Genomics_52_173
Author(s) : Gault J , Robinson M , Berger R , Drebing C , Logel J , Hopkins J , Moore T , Jacobs S , Meriwether J , Choi MJ , Kim EJ , Walton K , Buiting K , Davis A , Breese C , Freedman R , Leonard S
Ref : Genomics , 52 :173 , 1998
Abstract : Gault_1998_Genomics_52_173
ESTHER : Gault_1998_Genomics_52_173
PubMedSearch : Gault_1998_Genomics_52_173
PubMedID: 9782083

Title : Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus - Freedman_1997_Proc.Natl.Acad.Sci.U.S.A_94_587
Author(s) : Freedman R , Coon H , Myles-Worsley M , Orr-Urtreger A , Olincy A , Davis A , Polymeropoulos M , Holik J , Hopkins J , Hoff M , Rosenthal J , Waldo MC , Reimherr F , Wender P , Yaw J , Young DA , Breese CR , Adams C , Patterson D , Adler LE , Kruglyak L , Leonard S , Byerley W
Ref : Proc Natl Acad Sci U S A , 94 :587 , 1997
Abstract : Freedman_1997_Proc.Natl.Acad.Sci.U.S.A_94_587
ESTHER : Freedman_1997_Proc.Natl.Acad.Sci.U.S.A_94_587
PubMedSearch : Freedman_1997_Proc.Natl.Acad.Sci.U.S.A_94_587
PubMedID: 9012828